xuling Z.

Xuling Z. has a strong background in biochemistry and enzymology, holding a PhD from Cornell University and a Master's degree in biophysical chemistry from New York University. Xuling Z. began academic training as a graduate student researcher at Cornell University from 2007 to 2011, contributing to significant discoveries in diphthamide biosynthesis and the mechanism of CD38. Xuling Z. continued to expand expertise through postdoctoral fellowships at Harvard Medical School and MIT. From 2015 to 2020, Xuling Z. held roles at Moderna, advancing from Scientist to Associate Director, contributing to crucial research and development initiatives in the biotechnology field.